You may feel you only just got comfortable saying remdesivir and ivermectin and hydroxychloroquine — but there’s another group of drugs to get to know when it comes to Omicron and COVID-19.
To help navigate what they are, The Conversation spoke with Kaiser’s infectious disease specialist Dr. Tarquin Collins. He walked us through four drugs, starting with Paxlovid.
This interview aired on The Conversation on Jan. 12, 2022. The Conversation airs weekdays at 11 a.m. on HPR-1.
"local" - Google News
January 13, 2022 at 08:34AM
https://ift.tt/3flMnbG
Local doctor talks risks and benefits of 4 new COVID-19 drugs - Hawaiipublicradio
"local" - Google News
https://ift.tt/2WoMCc3
https://ift.tt/2KVQLik
Bagikan Berita Ini
0 Response to "Local doctor talks risks and benefits of 4 new COVID-19 drugs - Hawaiipublicradio"
Post a Comment